Clinical Trial Update: Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing real-world effectiveness of Symbicort single inhaler therapy in asthma, sponsored by AstraZeneca, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED